AI Article Synopsis
Article Abstract
Several monoclonal antibodies against Toxoplasma gondii were parasiticidal in the presence of normal human serum as measured by reduction in plaque titer or in assays that detected lysis. One monoclonal antibody, G, was used to select a resistant mutant from a large population of chemically mutagenized wild-type parasites. This mutant retained the wild-type sensitivity to other monoclonal antibodies and to polyclonal antisera. A comparison of surface radioiodinated wild-type and mutant parasites by using one and two-dimensional electrophoresis showed that the mutant lacked a protein (or proteins) of approximate m.w. 22,000. An immunoprecipitation procedure using monoclonal antibody G yielded a protein(s) of this m.w. from surface radioiodinated wild-type T. gondii but not from surface radioiodinated mutant parasites.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics.
Nucl Med Biol
June 2024
Duke University, Durham, NC 27710, USA. Electronic address:
Introduction: Single domain antibody fragments (sdAbs) are an appealing scaffold for radiopharmaceutical development due to their small size (~15 kDa), high solubility, high stability, and excellent tumor penetration. Previously, we developed NB7 sdAb, which has very high affinity for an epitope on PSMA that is different from those targeted by small molecule PSMA inhibitors. Herein, we evaluated NB7 after radioiodination using [*I]SGMIB (1,3,4-isomer) and iso-[*I]SGMIB (1,3,5-isomer), as well as their At-labeled analogues.
View Article and Find Full Text PDFPhase 1 study of intraventricular I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
J Hematol Oncol
November 2022
Departments of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 429, New York, NY, 10065, USA.
Background: The prognosis for metastatic and recurrent tumors of the central nervous system (CNS) remains dismal, and the need for newer therapeutic targets and modalities is critical. The cell surface glycoprotein B7H3 is expressed on a range of solid tumors with a restricted expression on normal tissues. We hypothesized that compartmental radioimmunotherapy (cRIT) with the anti-B7H3 murine monoclonal antibody omburtamab injected intraventricularly could safely target CNS malignancies.
View Article and Find Full Text PDFCopper-mediated radioiodination and radiobromination via aryl boronic precursor and its application to I/Br-labeled prostate-specific membrane antigen imaging probes.
Bioorg Med Chem
September 2022
Department of Radiation-Applied Biology Research, Takasaki Advanced Radiation Research Institute, National Institutes for Quantum Science and Technology, 1233 Watanuki-machi, Takasaki, Gunma 370-1292, Japan.
Prostate-specific membrane antigen (PSMA), expressed in prostate cancer cells, is being investigated extensively worldwide as a target for imaging and therapy of prostate cancer. Various radioiodinated PSMA imaging probes have been developed, and their structure has a peptidomimetic urea-based skeleton as a pharmacophore. For direct radioiodination of molecules containing these peptidomimetic structures, prior studies performed radioiododestannylation or electrophilic radioiodination of tyrosine residues.
View Article and Find Full Text PDFRadioiodination of extravesicular surface constituents to study the biocorona, cell trafficking and storage stability of extracellular vesicles.
Biochim Biophys Acta Gen Subj
February 2022
Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, United States of America; Engineering Research Accelerator, Carnegie Mellon University, Pittsburgh, PA, United States of America. Electronic address:
Background: Extracellular vesicles (EVs) are produced by all cell types and serve as biological packets delivering a wide variety of molecules for cell-to-cell communication. However, the biology of the EV extravesicular surface domain that we have termed EV 'biocorona' remains underexplored. Upon cell secretion, EVs possess an innate biocorona containing membrane integral and peripheral constituents that is modified by acquired constituents post secretion.
View Article and Find Full Text PDFHybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy.
Pharmaceutics
November 2021
Faculty of Chemistry, University of Warsaw, Pasteura 1 Str., 02-093 Warsaw, Poland.
Superparamagnetic iron oxide nanoparticles (SPIONs) are widely used for biomedical applications for their outstanding properties such as facile functionalization and doping with different metals, high surface-to-volume ratio, superparamagnetism, and biocompatibility. This study was designed to synthesize and investigate multifunctional nanoparticle conjugate to act as both a magnetic agent, anticancer immunological drug, and radiopharmaceutic for anticancer therapy. The carrier, Ho doped iron oxide, was coated with an Au layer, creating core-shell nanoparticles ([Ho] FeO@Au.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!